Compare UTZ & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UTZ | TOI |
|---|---|---|
| Founded | 2018 | 2007 |
| Country | United States | United States |
| Employees | N/A | 641 |
| Industry | Packaged Foods | Medical/Nursing Services |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 662.3M | 565.9M |
| IPO Year | 2018 | N/A |
| Metric | UTZ | TOI |
|---|---|---|
| Price | $14.10 | $5.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $11.93 | $6.67 |
| AVG Volume (30 Days) | ★ 5.0M | 2.2M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.32% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,438,800,000.00 | N/A |
| Revenue This Year | $5.16 | $30.15 |
| Revenue Next Year | $1.45 | $25.77 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2.09 | N/A |
| 52 Week Low | $6.78 | $2.32 |
| 52 Week High | $14.44 | $6.67 |
| Indicator | UTZ | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 86.49 | 43.91 |
| Support Level | $7.10 | $4.90 |
| Resistance Level | N/A | $5.63 |
| Average True Range (ATR) | 0.24 | 0.42 |
| MACD | 0.77 | -0.12 |
| Stochastic Oscillator | 99.43 | 2.71 |
Utz Brands Inc is a manufacturer of branded salty snacks based in the United States. It produces various salty snack foods, including potato chips, tortilla chips, pretzels, cheese snacks, party mixes, pork skins, ready-to-eat popcorn, and other snacks, which include salsa and dips. These products are offered through its flagship brands like Utz, On The Border, Zapp's, and Boulder Canyon, along with other brands, including Golden Flake, Miguelito's, Hawaiian, Bachman, Tim's Cascade, Dirty Potato Chips, TGI Fridays, and Vitner's. The company's products are packaged in a variety of different sizes and configurations, ranging from individual packages to shareable bulk containers. It also sells certain third-party branded products through its distribution network.
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.